Related Experiment Video
Updated: Apr 25, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
1.2K
Completeness and validity in a national clinical thyroid cancer database: DATHYRCA
Stefano Christian Londero1, Jes Sloth Mathiesen1, Annelise Krogdahl2
1Department of ENT Head & Neck Surgery, Odense University Hospital, Denmark.
Cancer Epidemiology
|August 19, 2014
Summary
The Danish national thyroid cancer database (DATHYRCA) demonstrates high completeness and validity. This cancer registry is reliable for national thyroid carcinoma research and reporting.
Area of Science:
- Oncology
- Public Health
- Health Informatics
Background:
- The Danish national clinical thyroid cancer database (DATHYRCA) has been operational since 1996.
- No prior data quality assessment had been conducted for DATHYRCA.
Purpose of the Study:
- To evaluate the completeness of case ascertainment and registration in the DATHYRCA.
- To assess the data validity of the DATHYRCA.
Main Methods:
- A national prospective cohort study was conducted in Denmark.
- Completeness was assessed using independent case ascertainment against governmental registries.
- Validity was evaluated using the reabstracted record method on 100 randomly selected cases.
Main Results:
- DATHYRCA contains 1934 thyroid carcinoma cases.
- Case ascertainment completeness was estimated at 90.9%.
- Registration completeness exceeded 90% for most variables, with excellent inter- and intra-observer agreement on diagnoses.
Conclusions:
- National clinical cancer databases can achieve satisfactory completeness and validity.
- The DATHYRCA database is reliable for national thyroid carcinoma surveillance.
- Public health insurance and governmental databases facilitate robust cancer registry development.
Keywords:
AgreementCompletenessDatabaseEpidemiologyNational registryThyroid carcinomaValidationValidityMore Related Videos
Related Concept Videos
01:20Synthesis and Regulation of Thyroid Hormones
7.0K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.0K
01:23The Thyroid Gland
6.9K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
6.9K
01:27Hyperthyroidism II: Pathophysiology
18
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
18
01:24Graves Disease II: Pathophysiology
15
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
15